The treatment of childhood Hodgkin lymphoma: Improved survival in a developing country

References

• Hudson MM, Onciu M, Donaldson SS. Hodgkin lymphoma. Principles and Practice of Pediatric Oncology5^th ed, PA Pizzo, DG Poplack. Lippincott Williams & Wilkins, Philadelphia 2006; p. 695–721
   Google Scholar
• Çavdar AO, Taçoy A, Babacan E, Gözdaşoğlu S, Arcasoy A, Topuz U, et al. Hodgkin's disease in Turkish children: A clinical and histopathological analysis. J Natl Cancer Inst 1977; 58: 479–81
   PubMedGoogle Scholar
• Ertem U, Duru F, Dağdemir A, Taçyildiz N, Pamir A, Akçayöz A, et al. Hodgkin's disease in 82 Turkish children diagnosed over a 10-year period: Epidemiological, clinical, and histopathologic features and prognosis with prolonged chemotherapy. Pediatr Hematol Oncol 1997; 14: 359–66
   PubMed Web of Science ®Google Scholar
• Büyükpamukçu M, Atahan L, Çağlar M, Kutluk T, Akyüz C, Hazar V. Hodgkin's disease in Turkish children: Clinical characteristics and treatment results of 210 patients. Pediatr Hematol Oncol 1999; 16: 119–29
   PubMed Web of Science ®Google Scholar
• Gözdaşoğlu S, Ünal E, Ertem M, Yavuz G, Pamir A, Taçyildiz N, et al. Modified OPPA/COPP chemotherapy and involved-field radiation therapy for the treatment of Hodgkin's disease in Turkish children. Turk J Haematol 2001; 18: 47–52
   Google Scholar
• Çavdar AO, Gözdaşoğlu S, Yavuz G, Unal E, Pamir A, Taçyildiz N, et al. Characteristics of early type-I pattern (0–6 years) Hodgkin's disease in Turkish children. Turk J Haematol 2002; 19: 55–62
   PubMedGoogle Scholar
• Karimi M, Yarmohammadi H, Ghavanini AA, Kumar PV. Epidemiological surveillance of pediatric Hodgkin's disease in southern Iran. Med Sci Monit 2002; 8: CR572–5
   PubMedGoogle Scholar
• Oguz A, Karadeniz C, Okur FV, Çitak EC, Pinarli FG, Bora H, et al. Prognostic factors and treatment outcome in childhood Hodgkin disease. Pediatr Blood Cancer 2005; 45: 670–5
   PubMed Web of Science ®Google Scholar
• Hjalgrim H, Smedby KE, Rostgaard K, Molin D, Hamilton-Dutoit S, Chang ET, et al. Infectious mononucleosis, childhood social environment, and risk of Hodgkin Lymphoma. Cancer Res 2007; 67: 2382–8
   PubMed Web of Science ®Google Scholar
• Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, et al. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol 2003; 21: 2026–33
   PubMed Web of Science ®Google Scholar
• Hudson MM, Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, et al. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol 2004; 22: 4541–50
   PubMed Web of Science ®Google Scholar
• Hakvoort-Cammel FGAJ, Buitendijk S, van den Heuvel-Eibrink M, Hahlen K. Treatment of pediatric Hodgkin disease avoiding radiotherapy: Excellent outcome with the Rotterdam-HD-84-protocol. Pediatr Blood Cancer 2004; 43: 8–16
   PubMed Web of Science ®Google Scholar
• Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, et al. POG 8625: Randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with stages I, IIA, IIIA1 Hodgkin disease. J Pediatr Hematol Oncol 2006; 28: 362–8
   PubMed Web of Science ®Google Scholar
• Tebbi CK, Mendenhall N, London WB, Williams JL, de Alarcon PA, Chauvenet AR; A report from the Children's Oncology Group. Treatment of stage I, IIA, IIIA1 pediatric Hodgkin's disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: A Pediatric Oncology Group (POG) study. Pediatr Blood Cancer 2006;46:198–202.
   PubMed Web of Science ®Google Scholar
• Clavel J, Steliarova-Foucher E, Berger C, Danon S, Valerianova Z. Hodgkin's disease incidence and survival in European children and adolescents (1978–1997): Report from the Automated Cancer Information System project. Eur J Cancer 2006; 42: 2037–49
   PubMed Web of Science ®Google Scholar
• Nachman JB, Sposto R, Herzog P, Gilchrist GS, Wolden SL, Thomson J, et al. For the Children's Cancer Group. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 2002; 20: 3765–71
   PubMed Web of Science ®Google Scholar
• Capra M, Hewitt M, Radford M, Hayward J, Weston CL, Machin D. On behalf of Children's Cancer and Leukaemia Group (formerly UKCCSG). Long-term outcome in children with Hodgkin's lymphoma: The United Kingdom Children's Cancer Study Group HD82 trial. Eur J Cancer 2007;43:1171–9.
   PubMedGoogle Scholar
• Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7: 1630–6
   PubMed Web of Science ®Google Scholar
• Barista I, Varan A, Ozyar E. Bimodal age distribution in Hodgkin's disease and nasopharyngeal carcinoma. Med Hypotheses 2007; 68: 1421
   PubMed Web of Science ®Google Scholar
• Gulley ML, Eagan PA, Quintanilla-Martinez L, Picado AL, Smir BN, Childs C, et al. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: Association with mixed cellularity subtype and Hispanic American ethnicity. Blood 1994; 83: 1595–602
   PubMed Web of Science ®Google Scholar
• Stoneham S, Ashley S, Pinkerton R, Hewitt M, Wallace WHB, Shankar AG. On behalf of Children's Cancer and Leukaemia Group (formerly UKCCSG). Hodgkin's lymphoma in children aged 5 years or less-the United Kingdom experience. Eur J Cancer 2007; 43: 1415–21
   PubMed Web of Science ®Google Scholar
• Hsu SC, Metzger ML, Hudson MM, Pedrosa F, Lins M, Pedrosa M, et al. Comparison of treatment outcomes of childhood Hodgkin's lymphoma in two US centers and a center in Recife, Brazil. Pediatr Blood Cancer 2007; 49: 139–44
   PubMed Web of Science ®Google Scholar
• Spitz MR, Sider JG, Cole Johnson C, Butler JJ, Pollack ES, Newell GR. Ethnic patterns of Hodgkin's disease incidence among children and adolsescents in the United States, 1973–82. J Natl Cancer Inst 1986; 76: 235–9
   PubMedGoogle Scholar
• Arya LS, Dinand V, Thavaraj V, Bakhshi S, Dawar R, Rath GK, et al. Hodgkin's disease in Indian children: Outcome with chemotherapy alone. Pediatr Blood Cancer 2006; 46: 26–34
   PubMed Web of Science ®Google Scholar